MSN Laboratories Private Limited — Dapagliflozin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Dapagliflozin · $825.0K export value · DGFT Verified
MSN Laboratories Private Limited is the #11 Indian exporter of Dapagliflozin with $825.0K in export value and 42 verified shipments. MSN Laboratories Private Limited holds a 1.7% market share in Dapagliflozin exports across 8 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Dapagliflozin Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Dapagliflozin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| LEBANON | $199.4K | 6 | 34.6% |
| UNITED KINGDOM | $169.3K | 6 | 29.4% |
| SAUDI ARABIA | $142.7K | 4 | 24.8% |
| SOUTH AFRICA | $63.0K | 6 | 10.9% |
| BRAZIL | $1.3K | 15 | 0.2% |
| KOREA,REPUBLIC OF | $324 | 2 | 0.1% |
| COSTA RICA | $143 | 2 | 0.0% |
| MEXICO | $5 | 1 | 0.0% |
MSN Laboratories Private Limited exports Dapagliflozin to 8 countries. The largest destination is LEBANON accounting for 34.6% of MSN Laboratories Private Limited's Dapagliflozin shipments, followed by UNITED KINGDOM (29.4%) and SAUDI ARABIA (24.8%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Dapagliflozin from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BENTA SAL | LEBANON | $199.4K | 6 |
| MSN LABORATORIES EUROPE LIMITED | UNITED KINGDOM | $169.3K | 4 |
| SUDAIR PHARMA COMPANY | SAUDI ARABIA | $142.7K | 4 |
| DP LOGISTIC PTY LTD | SOUTH AFRICA | $62.8K | 4 |
| SAFELAB TRANSPORTES LTDA | BRAZIL | $962 | 4 |
| MYUNGMOON PHARMACEUTICALS CO., LTD | KOREA,REPUBLIC OF | $224 | 1 |
| SAFE LAB LOGISTICS SAFELAB TRANSPORTES LIMITED A RUA | BRAZIL | $181 | 2 |
| GRUPO FARMANOVA S A | COSTA RICA | $143 | 2 |
| ABBOTT LABORATORIES SA | SOUTH AFRICA | $135 | 1 |
| NOVARTIS BIOCIENCIAS S.A. | BRAZIL | $110 | 9 |
MSN Laboratories Private Limited supplies Dapagliflozin to 14 buyers globally. The largest buyer is BENTA SAL (LEBANON), followed by MSN LABORATORIES EUROPE LIMITED (UNITED KINGDOM) and SUDAIR PHARMA COMPANY (SAUDI ARABIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Dapagliflozin Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $34.4M worth of Dapagliflozin through 5,104 shipments from 254 suppliers to 113 countries, serving 502 buyers globally. MSN Laboratories Private Limited contributes $825.0K to this total, accounting for 1.7% of India's Dapagliflozin exports. MSN Laboratories Private Limited ships Dapagliflozin to 8 countries through 14 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Dapagliflozin Exports?
MSN Laboratories Private Limited's average Dapagliflozin shipment value is $19.6K per consignment, based on 42 shipments totaling $825.0K. The largest destination is LEBANON (34.6% of MSN Laboratories Private Limited's Dapagliflozin exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Dapagliflozin Exporters?
MSN Laboratories Private Limited ranks #11 among 254 Indian Dapagliflozin exporters with a 1.7% market share. The top 3 exporters are MICRO LABS LIMITED ($7.7M), AJANTA PHARMA LIMITED ($5.2M), ALEMBIC PHARMACEUTICALS LIMITED ($4.8M). MSN Laboratories Private Limited processed 42 shipments to 8 destination countries.
What Dapagliflozin Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DAPAGLIFLOZIN 10MG 60x10 SUDAIR SA | $121.0K | 3 |
| DAPAGLIFLOZIN TAB 10MG 28 S UK | $100.0K | 2 |
| Dapagliflozin 10mg 500s BENTA LB | $76.6K | 2 |
| Dapagliflozin 10mg (500s) BENTA - LB | $64.0K | 2 |
| DAPAGLIFLOZIN TAB 10MG 28 s UK 51968 X28 s PACK 1455104 NO s | $50.0K | 1 |
| DAPAGLIFLOZIN 10MG (500'S) BENTA - LB | $45.0K | 1 |
| Dapagliflozin 10mg( 3x10s)DRL-ZA | $38.7K | 2 |
| Dapagliflozin 5mg( 3x10s)DRL-ZA | $24.2K | 2 |
| DAPAGLIFLOZIN 5MG 60x10 SUDAIR SA | $21.7K | 1 |
| DAPAGLIFLOZIN TAB 5MG 28 s UK 14336 X 28 s PACK 401408 NO s | $19.3K | 1 |
MSN Laboratories Private Limited exports 26 distinct Dapagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DAPAGLIFLOZIN 10MG 60x10 SUDAIR SA with 3 shipments worth $121.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Dapagliflozin to Key Markets
What MSN Laboratories Private Limited must comply with to export Dapagliflozin to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Dapagliflozin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | HETERO LABS LIMITED | $1.2M | 49 | 11 | $24.8K |
| 9 | SANDOZ PRIVATE LIMITED | $1.1M | 44 | 3 | $25.9K |
| 11 | MSN LABORATORIES PRIVATE LIMITED ★ | $825.0K | 42 | 8 | $19.6K |
| 14 | AUROBINDO PHARMA LTD | $688.9K | 51 | 2 | $13.5K |
| 15 | SAVA HEALTHCARE LIMITED | $681.6K | 535 | 2 | $1.3K |
MSN Laboratories Private Limited ranks #11 among 254 Indian Dapagliflozin exporters. Average shipment value of $19.6K compared to the market average of $135.5K. The closest competitors by value are HETERO LABS LIMITED and SANDOZ PRIVATE LIMITED.
Which Indian Ports Ship Dapagliflozin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,003 | 19.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 791 | 15.5% |
| DELHI AIR CARGO ACC (INDEL4) | 761 | 14.9% |
| DELHI AIR | 612 | 12.0% |
| Bombay Air | 194 | 3.8% |
| BANGALORE ACC (INBLR4) | 189 | 3.7% |
| BANGALORE AIR | 160 | 3.1% |
| NHAVA SHEVA SEA (INNSA1) | 136 | 2.7% |
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Dapagliflozin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Dapagliflozin, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dapagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dapagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 42 individual customs records matching MSN Laboratories Private Limited exporting Dapagliflozin, covering 26 formulations to 8 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 502+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dapagliflozin Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Dapagliflozin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Dapagliflozin Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dapagliflozin. For current shipment-level data, contact TransData Nexus.